Kaklamani et al. showed that some polymorphisms of the ADIPOQ and its receptor genes were associated with breast cancer [26], prostate cancer [27] and colorectal cancer [28] risk in Caucasian. This evidence concerns the gene ADIPOQ and prostate carcinoma.